Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
8.78
+0.21 (2.45%)
At close: Jan 13, 2026, 4:00 PM EST
8.80
+0.02 (0.23%)
Pre-market: Jan 14, 2026, 4:13 AM EST
Personalis Market Cap
Personalis has a market cap or net worth of $779.7 million as of January 14, 2026. Its market cap has increased by 80.27% in one year.
Market Cap
779.70M
Enterprise Value
671.06M
1-Year Change
80.27%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $779.70M, a decrease of -8.01%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 761.05M | 7.66% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |